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INTRODUCTION
Pregnancy  –induced  hypertensive  disease  (PIH),  in  particular 
preeclampsia/eclampsia,  remain  important  causes  of  maternal 
mortality and morbidity worldwide. The prevalence of PIH  was 43.1 
per  1000  pregnancies  in  a  retrospective  population-based  study  of 
200,000 births in North Carolina, USA (Savitz 1992). For the past ten 
years, PIH has been  the major cause of maternal mortality  in England 
and Wales, and 56 per cent of deaths due to PIH  were attributable to 
eclampsia   (DOH  report  on  confidential  enquiries   into   maternal 
deaths in the United Kingdom 1985-1987). The Philippine Obstetrical 
and  Gynecological  Society  committee  on  nationwide  Statistics 
reported  that  18.42  per  cent  of  maternal  deaths   were  due to  PIH 
(POGS 1994).
PIH also contributes to a   great extent towards  fetal wastage 
as per  latest  studies it  is  responsible  for 20% perinatal  deaths  and 
2-3% maternal deaths. 
PIH is defined as systolic blood  pressure  more than 140 mm of 
Hg   or diastolic  pressure more than 90mm Hg on 2 occasions 6 hrs 
apart in a previously  normotensive pregnant women and associated 
with oedema and proteinuria. 
The criteria for diagnosing PIH  are onset of hypertension  for 
the  first  time  after  20  weeks  of  pregnancy  and  patients  becoming 
normotentive after   delivery. 
This random study was taken up to evaluate the present  status 
of maternal and perinatal outcome  in mild and severe pre eclampsia 
and eclampsia   in comparison with 200 normotensive control group at 
Kilpauk Medical  College  Hospital  ,  Chennai  in a period of  2003 to 
2005.
 
AIM OF STUDY
1. To  study  the  maternal  and perinatal outcome  in  mild 
and  severe  pre Eclampsia   and Eclampsia in comparison to  the 
outcome      in  normal  gravidae between  the  period  of 2003 to 2005 
at government K.M.C. Hospital, Chennai.
2. To  study   the  factors  that  influence  the  maternal  and 
perinatal outcome   in mild, severe pre Eclampsia  and Eclampsia.
3. To identify the factors affecting the maternal and perinatal 
outcome adversely so as to take steps to modify those factors for the 
improvement of materno fetal outcome. 
4. To show the importance of proper antenatal, intranatal & 
postnatal care to improve the outcome. 
 
REVIEW OF LITERATURE
The  hypertensive  disorders  in  pregnancy  comprise  several 
disease  and  Syndromes  associated  with  high  blood  pressure.  The 
disorders  were  called  Toxemias  of  Pregnancy,  but  that  term  is  an 
ambiguous misnomer.
Hypertension  may  antedate  conception  or  arise  during 
Gestation,  or  in  the  early  puerperium.  It  is  often  accompanied  by 
Oedema and  Proteinuria  separately  or  together  and  occasionally  it 
culminates in convulsions and coma. The combined prevalence and 
incidence of the hypertensive disorders in pregnancy is probably about 
6 percent,  although vide variations have been alleged in relation to 
geographic, racial and socio economics factors.
The hypertensive disorders pose a serious threat to the Fetus 
and to the new- born infant who is often delivered prematurely either 
following  spontaneous  labour  or  by  therapeutic  termination  of 
pregnancy. 
MacGillvray in 1958 has found from his study that preeclampsia 
is  primarily  a  disorder  of  first  pregnancy  
(MacGillvray 1958.  Some observations on the incidence of pre-
eclampsia  -  Journal  of  obstetrics  and  Gynaecology  of  British 
Commonwealth 65:
The  current  hypothesis  of  Preeclampsia  is  a  disorder  of 
maternal  and  fetal   incompatibility.  This  is  consistent  with  the 
knowledge that Preeclampsia is more likely when there is an usually 
large trophoblast mass as with vesicular  pregnancy, placental hydrops 
and multiple pregnancies and shown by Chung et al., 1964 (Clinical 
Observations  on  some aspects  of  hydratiform  mole  journal  of 
obstetrics and gynaecology British Commonwealth 71) Jeffcoate 
and  Scott  1959  -  some  observation  of  placental  factor  in 
pregnancy toxemia American journal of obstetrics Gynaecology 
72). In  these circumstances it  is  postulated that  immune regulatory 
mechanism  of  normal  pregnancy  are  overwhelmed  by  the  size  of 
antigenic load of placenta, particularly as moles as androgenic in origin 
and this fact is reassured by Kojil and Ohamma 1977.
CLASSIFICATION OF PREGNANCY INDUCED HYPERTENSION 
 ISSHP classification 
Hypertension 
Diastolic BP of ≥110 mmHg on any one occasion 
(or)  Diastolic  BP of ≥ 90 mmHg on any two or more consecutive  
occasions ≥4 in apart.
Severe hypertension 
Diastolic BP ≥120 mm Hg on any one occasion 
(or)  Diastolic  Bp  ≥110mm  Hg  on  two  or  more  consecutive  
occasion ≥4h apart. 
Proteinuria
One 24h urine collection  with a total protein excretion of  ≥300 
mg/24h.
(or) Two midstream or catheter specimens of urine (collected  ≥4h  
apart) with ≥++ protein on reagent strip testing 
(or) 3 + protein (if urine SG <1.030 and pH ≤8).
Recurrent  Preeclampsia   is  diagnosed  when  hypertensive 
disorders  occur  in  two  or  more  pregnancies,  not  necessarily 
consecutive,  with  return of  the blood pressure to normal after  each 
delivery.
Pregnancy seems to be a screening test for later Hypertension. 
Gestational  hypertension  portends  a  high  likelihood  of  late  Chronic 
Hypertension.
MINIMUM CRITERIA OF DEFINING PREECLAMPSIA
Preeclampsia  is  a  clinical  diagnosis  encompassing  three 
elements (committee on obstetric  hypertension in pregnancy ACOG 
1996)
1. New  onset  hypertension  (defined  according  to  the  latest 
American college of obstetricians and gynecology bulletin simply 
as a blood pressure consistently more than 140/90 mm  Hg in 
previously normotensive women).
2. New onset Proteinuria defined as more than 300mg/24hrs or≥2+ 
on a clean catch dipstick in the absence of urinary infection)
3. New onset significant independent edema.
The diagnosis of PREECLAMPSIA should be made only after 20 
weeks gestation
In the past it has been recommended that an increment of 30 
mmHg systole  or  15 mmHg diastolic  blood  pressure  be used as a 
diagnostic  criterion,  even when absolute  values were  below 140/90 
mmHg. This criterion is  no longer  recommended because evidence 
shows that women in this group are not likely to suffer (Levine 2000, 
North  &  Colleagues1999  (24)  but  warrant  close  observation. 
Conventional mercury sphygmomanometer remains the gold standard 
for blood pressure measurement. Blood pressure should be measured 
with the women seated or at 450 reclined, with her feet supported or on 
the ground, and her arm at the level of the heart. The right arm should 
be used with the cuff  of appropriate size.  Electronic  blood pressure 
monitors may underestimate the true pressure. 
Nowadays it has been recommended that kortkoff phase V be 
used as a measure of diastolic pressure. (Brown et al 1998).
1. K4/K5  difference  is  smaller  in  hypertensive  than  in 
normotensive pregnant women.
2. K5  is  closer  to  the  actual  intra-arterial  pressure, 
physiologically  more accurate,  is  more reliably  detected 
and is reproducible.
3. K4 has limited reproducibility (shennam et al 1996)
PREECLAMPSIA is classified as either "mild" or "severe". There 
is no category of moderate preeclampsia. 
SEVERE PREECLAMPSIA (ACOG)
A diagnosis  of  severe Preeclampsia  should  be entertained in 
women with new onset proteinuric hypertension and one or more of 
the following complications.
I. Severe elevations of blood pressure ≥ 160/110 mmHg on 
2 occasions at least 6 hours apart.
II. Proteinuria (>5g/24h)
III. Oliguria  <500cc/24hrs
IV. Cerebral, visual symptoms like  blurred vision, 
scotomata, altered mental status, severe headache.
V. Symptoms of liver capsule distention (right upper 
quadrant or epigastric pain)
VI. Pulmonary Edema or cyanosis  
VII. Thrombocytopenia (<100000 platelets / mm3)
VIII. Hepatocellular injury (serum transaminase level > 2 
times normal)
IX. Fetal growth restriction 
THEORIES ABOUT CAUSES OF PREECLAMPSIA
1. Immunological mechanism - BARDEQUEZ(3)
There  is  immunological  resistance  to  invading  trophoblast  by 
maternal  immune  system.  Blocking  antibodies  and  T  helper  cells, 
interleukins, interferon, growth factors play a major role. This results in 
inadequate trophoblast invasion of myometrial spiral arterioles. 
2. Genetic predisposition - CHESLEY & COOPER 1986(6) 
Susceptibility  is  by  both  single  gene  and  multifactorial 
inheritance.
a. Women with angiotensin gene variant T232 had increased 
incidence
b. There is higher incidence of factor V Leiden mutation in 
Preeclamptic patients
3. Increased pressor response to angiotensinogen II - ABDUL 
KAREEM 1961 (1)
4. Altered vasoactive factors : VOLHARDT 1918 (45)
a. Endothelin  -  1.  A  potent  vasoconstrictor  produced  by 
endothelium is increased.
b. NITRIC  OXIDE:  A  potent  vasodilator  is  decreased. 
(Chang et al (5)
c. Reversal of PGI2 to TXA2 and vit.E ratio (Wang et al 1991 
Walsh 1985(41)
d. Vasoactive maternal  factor (VMF) has been imposed to 
cause  the  endothelial  changes  involved  in  the  patho 
physiology of PIH.
5. Oxidants and Antioxidants 
Hubal et al (18) have confirmed that Preeclampsia may have its 
origin in a disturbed oxidation mechanism. Under normal conditions 
equilibrium is maintained by anti oxidants. With increase in severity of 
Preeclampsia there is increase in lipid peroxidase and reduction in anti 
oxidants. Vit E lipid peroxidase cause endothelial damage.
6. Endothelial dysfunction : HAYMAN & ASS 2000(17) 
Deficiency  in  trophoblastic  invasion  of  placental  blood  spiral 
arteries  leads  to  poorly  perfused  fetoplacental  unit.  This  results  in 
secretion  of  plasminogen  activator  inhibitor,  into  the  maternal 
circulation  leading  to  activation  of  endothelial  cells  to  promote 
coagulation and increased sensitivity to vasopressor agents.
Banker  and  Coll  1995  have  shown  that  BEGF  levels  are 
increased in serum of  PE which may activate  endothelial  cells  and 
release of inflammatory substances. (Dekar & Sibai 1998(8)
7. Placental proteins 
Corticotrophin  releasing  factor,  HCG,  Activin  A,  Inhibin  A  are 
said to play a role.
8. Dietary deficiency: DAWSON, KELLY & Coauthors 
Mac  Gillivray  viewed  the  evidence  for  a  role  of  dietary 
deficiency  in  pathology  of  PE.  It  was  concluded  that  when 
concentration of calcium is low in extra cellular fluid, amount of ionic 
calcium entering cell  wall  increases making vascular smooth muscle 
more sensitive to excitation.
9. Hyperhomocystinemia ; COLLER ET AL 
Presence  of  infarcts  retroplacentally  is  said  to  be  cause  of 
elevated levels of circulatory homocysteine. This is due to atherosis 
formed at placental site.
 Elevated  levels  damage  endothelium  by  H202  generation 
depletes nitric oxide mediated detoxification of homocysteine. Elevated 
levels of factor V increase in prothrombin activation. 
PATHOPHYSIOLOGY OF PREECLAMPSIA
PRIMARY LEVEL 
Changes that occur in placenta and placental vascular bed are 
the two lesions that involve spiral arterioles which are the end arteries 
supplying intravascular space 
(REDEMAN 1991 (32)
a. Relative lack of trophoblastic infiltration of arterial  walls during 
placentation (Bloen et al 1972)
b. Acute atherosis (Robertson et al 1963(33)
c. Magnitude of defective trophoblast  invasion of spiral  arterioles 
correlated with severity of hypertensive disorder.
d. Lipid  accumulates  first  in  myometrial  cells  and  then  in 
macrophages (Madzli & Collegues 2000(20))
SECONDARY LEVEL 
1. Renal system 
a. Decreased uric acid clearance, decreased glomerular function, 
decreased renal blood flow, Proteinuria. Intrinsic renal changes 
cause by severe vasospasm
b. Renal  pathology  :  Proteinuria  reflects  advanced  disease 
associated  with  poor  prognosis  (Naeye  &  Friedman  1979) 
Glomerular endotheliosis (Sargo et Al 1959)
c. Urinary sediments reflects renal changes (Leduc et Al(19))
d. Renal clearance of urate decreased (Chesley & Williams 1945)
e. Hypocalciuria  (Taufield  et  Al  1987(40) because  of  increased 
tubular reabsorbtion
f. Hyperuricemia (Pollok et Al 1960)
g. Proteinuria  (Meyer  &  Colleagues  1994) Trace  or  negative 
Proteinuria  had  negative  predictive  value  only  34%  in 
hypertensive  women  3+  or  4+  Proteinuria  were  positively 
predictive of severe preeclampsia in only 36% of cases
II. Cardio vascular system:
a. Hemodynamic changes:
Increased arterial sensitivity to angiotensin II
Increased peripheral resistance
Decreased cardiac output
Increased BP
b. Blood volume
Hemo concentration,  Blood volume decreased in women with 
homozygous  for  T  234  angiotensin  genotype  associated  with 
preeclampsia (Silver & Associates 2001(35).
III. Coagulation system 
a. Intravascular coagulation and less often erythrocyte destruction 
commonly  in  PE  and  especially  Eclampsia 
(Baker & Cunningham 1999)
b. PT,  aPTT,  plasma  fibrinogen  level  are  unnecessary  in 
management of  hypertensive disorder of pregnancy  (Baker & 
Colleagues 1999)
c. Thrombin time somewhat prolonged in a third of cases
d. Thrombocytopenia results from platelet activation, consumption 
and  increased  platelet  production.  Platelet  aggregation  is 
decreased  compared  with  the  normal  increase  seen  in 
pregnancy (Baker & Counningham 1999)
e. Fragmentation  hemolysis:  (Sanchel  Ramos  1994(34)) 
Increased RBC fluidity in women with HELLP 
f. Antithrombin III lowered (Chang & Coworkers 1992(5))
g. Fibronectin elevated (Bru Baker & Colleagues 1992)
h. Thrombophilias  :  Clotting  factors  deficiencies  or  mutation 
associated wuth early onset of preeclampsia
IV.Hepatic System:
a. With severe preeclampsia there is  elevation of  liver  enzymes 
(Combes & Adams 1972)
b. Increased  hepatic  artery  resistance  by  Doppler  sonography 
(Ooster Hof & Coworkers9(28))
c. Periportal hemorrhagic necrosis in the periphery of liver (Barton 
& Colleagues)
d. HELLP  syndrome  :  Hemolysis,  elevated  liver  enzymes,  low 
platelet  (Deboer  &  Coworker  1991(9)),  Pritchard  and 
Associates 1954(30), Weinstein 1985(43))
IV. Endocrine system 
a. Increased plasma levels of renin
b. Angiotensin  II  and  aldosterone  are  decreased  
(Weir & Colleagues)
c. Arial  natriuretic  peptide  is  increased  in  women  with 
preeclampsia (Cunningham & Lindheimer 1999(7))
V. Fluid and Electrolyte System
a. Volume  of  extra  cellular  fluid  manifest  as  edema  in 
women with severe preeclampsia has expanded beyond 
the  normally  increased  volume  that  characterizes 
pregnancy
b. Electrolyte concentration do not differ appreciably in PIH 
women  compared with those of normal pregnancy. 
TERTIARY LEVEL 
Tertiary  systemic  effects  of  preeclampsia  secondary  to 
decompensation which presents as one of the following features
1. Eclampsia 7. HELLP Syndrome
2. Laryngeal edema 8. Retinal detachment 
3. Cerebral hemorrhage 9. Renal cortical 
necrosis
4. DIC 10. Pulmonary edema 
5. Corneal edema 11. ARDS
6. Hepatic rupture 
PREDISPOSING FACTORS OF PREECLAMPSIA 
1. Age 
Young primi < 20 years
All patients > 30 years Bobrowski & Bottoms 1995
Showed increased incidence of HT & PIH > 35 years
2. Parity 
Primi have incidence of 11.9% and multi have 4.7% Clinical Obs 
and Gyn. The incidence is 24$ new paternity multipara because 
of shorter period of Sperm exposure preceding conception.
3. Race  
Davis in 1970 found an increased incidence in Muslims, Jews & 
Arabs. Africoamerican ethnicity is quoted to have increased incidence 
by Sibai 1997, Walker 2000
4. Social Status 
Women  of  low  social  economic  status  are  reported  to  have 
greater incidence of PIH, PE, Eclampsia. But Duffer & Mac Gillivray - 
1968  found  that  difference   between  social  classes  are  small  if 
allowances  are  made  for  age,  parity  and  levels  of  antenatal  and 
intrapartum care. Baird and colleagues 1969 said that incidence was 
not different among five socioeconomic statuses.  
5. Previous H/O Preeclampsia 
The risk of preeclampsia in subsequent pregnancies is higher 
when it is
a.  severe earlier and associated with low birth weight
b. Risk increases on increasing  maternal  age and interval 
between pregnancies. 
Sibai  et  al  studied subsequent  pregnancy outcome in women 
with severe PE in  first pregnancy
Risk of developing Eclampsia - 1.3%
Preeclampsia - 4.5%
Perinatal mortality - 5.9%
Norwegian  study  showed  risk  of  13.1%  of  PE  in  second 
pregnancy.
6. Family history
Severe preeclampsia, Eclampsia has a familial tendency. There 
is three fold increase of preeclampsia and four fold increase of 
severe  PE.  Chesley  et  al  (6)  found  26% incidence  of  PE in 
daughters. Lie et al found odds ratio 2.23 in sisters.
7. Pregnancy associated : Early onset
a. Twin gestation: Four fold increased risk Incidence of PE 
25.3%.  This  is  due  to  hyperplacentosis  with  increased 
placental hormone secretion relative placental ischemia or 
immunological reaction to the large placental mass
b. Molar pregnancy: confined to large rapidly growing moles 
in  which  the  incidence  of  PE  is  70%  
(Page 1939(29)). With small slowly growing moles there is 
no increased incidence of PE.
c. Hydrops  fetalis:  Increased  incidence  due  to 
hyperplacentosis.
d. Congenital malformations: In pregnancies complicated by 
triploidy,  the  risk  of  developing  PE  or  hypertension  in 
second trimester is 35% due to placentomegaly. 
8. Urinary tract Infection 
UTI  resulting  in  an  increased  production  of  inflammatory 
products,  cytokines,  free  radical  species  and  proteolytic  enzymes 
causes endothelial dysfunction (Schieve et al) 
9. Underlying Disorders
a. Chronic  hypertension  is  encountered  in  approximately 
30-40% of early onset severe PE.
b. Underlying renal disorder : 20% have superimposed PE
c. Obesity, insulin resistance & Diabetes stone et al - BMI is 
an independent risk of severe PE
i. Obesity correlated with hypertension by expanded blood 
volume, Cardiac output to meet the increased metabolic 
demands.
ii. Obesity  -  dyslipidemia  -  delivery  of  free  fatty  acids  to 
tissue, higher cholesterol / TG ratio, insulin resistance & 
hyperinsulinemia.
iii. Adipocytes  release  TNF  alpha  thereby  involved  in 
aggravating cytokine mediated oxidative stress.
iv. Insulin  resistance  /  hyperinsulinemia  associated  with 
increased  sympathetic  activity  and/or  increased  tubular 
sodium  reabsorbtion  thereby  producing  direct 
Hemodynamic changes.
v. Overt  DM -  30% PE especially  when vascular  changes 
present.  Khan  &  Daya  showed  odds  of  having  PE 
increased by 20% per nmol/L increase in plasma glucose 
level.
10. Smoking
Decreases  incidence  of  PE  since  it  causes  a  significant 
reduction in HCG and estradiol level due to direct effect on the 
placental function (Bernstein et al 1989)
Management Objectives in severe preeclampsia  
There is no preventive therapy against preeclampsia available at 
present even though aspirin, calcium magnesium, fish oil have been 
tried. Severe preeclampsia is associated with maternal complications 
like  HELLP,  Eclampsia,  cerebral  manifestations,  abruption,  fetal 
complications  like  IUGR,  IUD,  preterm  delivery.  As  termination  of 
pregnancy  remains  the  only  cure,  the  primary  objective  in  the 
management  of  severe  preeclampsia  is  to  effect  timely  delivery  in 
order to
 Prevent maternal morbidity and mortality
 Deliver a baby in an optimal condition,  thereby minimizing 
perinatal morbidity and mortality. 
In all circumstances, the well being of the mother is primary. In 
some circumstances, delays seriously jeopardize the well being of the 
mother, fetus or both.
MATERIALS AND METHODS
200  Cases  of  pregnancy  induced  hypertension  complicating 
pregnancy admitted with duration of gestation between 21 weeks to 40 
weeks  were  studied,  200  cases  of  normotensive  patients  of  same 
period of gestation were taken as control group. 
Group A- Normotensive control patients.
Group B- Pregnancy induced hypertension patients.
Apart  from  routine  clinical  examination  the  following  aspects 
were studied in the mother and fetus. 
I. STUDY OF MOTHER 
Age,  gravidity  ,  parity,  socioeconomic  status,  booking  status, 
previous  obstetric   history,  family  history  of  hypertension,  chronic 
nephritis, past  history of hypertension, chronic nephritis, complications 
during  pregnancy  like   anemia,   Hypoproteinemia,   APH,  PPH, 
malpresentation malposition, urinary tract infection, diabetics mellitus, 
multiple pregnancy,   abnormal liver function tests, with ( or) without 
HELLP syndrome, fever, aspiration, DIC, renal failure, external injury, 
PROM , PPROM were noted. 
Investigations like blood urea, sugar,  serum creatinine,  serum 
proteins, uric acid, electrolytes, serum fibrinogen, liver function tests 
including  SGOT  (AST),  SGPT  (ALT),  Alkaline  Phosphatase, 
prothrombin time, 24hrs urinary protein, specific gravity were noted. 
On  general  examination  distribution  of  Oedema  was  noted. 
Height,    weight  of  patients  recorded.  Optic  Fundus  examined 
periodically for the presence of vascular changes. BP Checked   2 hrly 
&  maximum  pressure  recorded  since  admission  were  noted.  BP 
rechecked 24hrs 48 hrs, 1 week after delivery and on every visit up to 
6 weeks. 
Drugs   like sedatives anti hypertensive & anticonvulsant were 
noted. 
Follow up advice given to the patient for visit once in 2weeks up 
to 6 weeks.  
II. STUDY OF FETUS 
Apgar  at  one  minute  after  birth  was  noted.  sex  incidence, 
weight   of  the babies  at  the time of  delivery,  maturity  of  the baby, 
perinatal  mortality,  sex  incidence  of  fetal  loss,  ultrasonographic 
evaluation at different gestational age were noted . These babies were 
followed  in  the  neonatal  period  few  babies  were  followed  up  to  6 
months.  
RESULTS & OBSERVATION
Table - 1
Age Distribution in Normotensive and Hypertension
Complicating pregnancy
Age in Years
Normotensive Patients PIH (mild + Severe + Eclampsia)
No. of 
Patients %
No. of 
Patients %
< 20 years 60 30 63 31.5
21-25 89 44.5 84 42
26-30 yrs 30 15 33 16.5
31-35 yrs 15 7.5 13 6.5
36 yrs and above 6 3 7 3.5
Total No. of 
Patients
200 100 200 100
P =0.96522563 X2  =0.58 Statistically NOT SIGNIFICANT
In normotensive control patients maximum (44.5%) of patients 
belong to 21 to 25yrs of age, next 30% belong to ≤ 20 yrs of age, 15% 
belong to 26 to 30 yrs of age,  7.5% belong to 31 to 35 yrs of age, 
least 3% are 36yrs  and above. Almost the same situation prevailing in 
PIH patients also. Maximum 42% of patients belong to 21 to 25 yrs 
age group.   Next 31.5% belong to less than 20 yrs  of  age,  16.5% 
belong to 26 to 30 yrs of age, 6.5% belong to 31 to 35 yrs of age, least 
3.5% of patients are 36 years and above.
Table - 2
Gravidity in normal and PIH Patients
Gravida
Normotensive
(Control pts 
200)
Mild PIH 92 
patients
Severe PIH 
68 patients
Eclampsia 40 
patients
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
G1 
(Primi)
96 48 58 29 36 1
8
26 13
G2 70 35 24 12 22 1
1
11 5.5
G3 30 15 7 3.5 8 4 3 1.5
G4 and 
Above
4 2 3 1.5 2 1 Nil Nil
P =0.06851916  X2 =7.11 statistically NOT SIGNIFICANT
In  normotensive  patients  (total  200)  96  patients  (48%)  were 
primi Gravida.  70 patients (35%) were second Gravida.  30 patients 
(15%)  were  Gravida  III  and  4  patients  (2%)  were  Gravida  IV  and 
above.
In  mild  preeclampsia,   in  a total  of   92 patients  58 patients 
(29%) were primi Gravida 24 patients (12%) were second Gravida 7 
patients (3.5%) were third Gravida. 3 patients  (1.5%) were Gravida 4 
and above.
In  severe  preeclampsia  patients  (total  68  patients)  36  (18%) 
were primi Gravida, 22 patient (11%) were second Gravida, 8 patients 
(4%) were III Gravida. Where as Gravida 4 and above are 2 patients 
(1%).  In  eclamptic  patients  (total  40)  26 patients  (13%)  were  primi 
Gravida, 11 patients (5.5%) were Gravida II, 3 patients (1.5%) were III 
Gravida,  Gravida  IV  and above  were  not  present  &  there  were  no 
elderly primi Gravida.
TABLE -3
PARITY DISTRIBUTION
Gravida
Normotensive
(Control pts 
200)
Mild PIH 92 
patients
Severe PIH 68 
patients
Eclampsia
40 pts
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Nullipara 
(Para `o')
96 48 58 29 36 18 26 13
Para I 76 38 28 14 25 12.
5
12 6
Para II 26 13 4 2 5 25 2 1
Para III & 
above
2 1 2 1 2 1 Nil Nil
P =0.01638577  X2 = 10.27 Statistically  SIGNIFICANT.
The parity distribution in normotensive group is as follows.
96 cases (48%) were Nullipara (Para 0), 76 cases (38%) were 
Para I, 26 patients (13%) were Para II, 2 patients (1%) were Para III 
and above. In mild preeclampsia (total 92), 58 (29%) cases were Para 
0 (Nullipara), 28 (14%) cases were Para I and 4 patients (2%) were 
Para II, 2 cases (1%) were Para III and above.
In severe PIH (total 68 patients) 36 cases (18%) were Para 0, 
25 patients (12.5%) were Para I and 5 patients (2.5%) were Para II, 2 
patients (1%) were Para III and above.
In Eclampsia (total 40 cases), 26 (13%) cases were Para 0, 12 
cases (6%) were Para I, 2 cases (1%) were Para II, no patients were 
above Para II.
Table - 4
BOOKING STATUS
Booking 
Status
Normotensive
Control pts
200 cases
Mild PIH 
92 patients
Severe PIH 
68 cases
Eclampsia
40 cases
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Unbooke
d 
patients
78 39 70 35 52 26 34 17
Booked 122 61 22 11 16 8 6 3
P =0.000001  X2 =28.53 Statistically SIGNIFICANT.
In a total of 200 normotensive control  patients 78 (39%) were 
Unbooked, 122 (61%) were booked.
In a total  of 92 mild PIH cases 70 (35%) were unbooked,  22 
case (11%) were booked.
In  severe  PIH (total  68  cases)  52  (26%)  were  unbooked,  16 
cases (8%) were  booked.  In Eclampsia (40cases),  34 cases (17%) 
were unbooked, 6 patients (3%) were booked.
Table - 5
Socio economic status in normotensive and hypertensive 
patients
Socio 
Economic 
class
Normotensive
200 patients
Mild PIH 
92 patients
Severe PIH 
68 patients
Eclampsia
40 pts
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Class I Nil - Nil - Nil - Nil -
Class I Nil - Nil - Nil - Nil -
Class III 22 11 3 1.5 1 0.5 Nil -
Class IV 52 26 29 14.
5
18 9 7 3.5
Class V 126 63 60 30 49 24.5 33 16.5
In 200 normotensive (control) patients, no one belongs to class I 
(or) class II socioeconomic status. 22 cases (11%) belong to class III, 
52  (26%)  were  in  class  IV  and  majority  126  cases  (63%)  were  in 
lowest class V socioeconomic status. In 92 cases of mild PIH none 
belongs to class I,  II.  Only 3 patients (1.5%) belong to class III,  29 
(14.5%) cases were class IV, 60 patients (30%) were class.
In severe PIH patients (68 cases) Class I,  II  cases were NIL, 
only 1 patient (0.5%) is class III 18(9%) were class IV, and 49 cases 
(24.5%) were  class V. In eclamptic patients (total 40) none belongs to 
class I, II and III. 7(3.5%) patients belong to class IV and majority 33 
patients (16.5%) were from lowest socio economic class V.
Table - 6
Previous BOH in normotensive and Hypertensive patients
Previous 
history
Normotensive
200 patients
Mild PIH 
92 patients
Severe PIH 
68 patients
Eclampsia
40 pts
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Previous 
IUD
Nil - Nil - 1 0.5 Nil -
Previous 
abortions
8 4 6 3 3 1.5 1 0.5
In normotensive controls past  obstetric  history reveals  8 (4%) 
patients  had  previous  abortions.  There  is  no  previous  IUD  in  this 
group.
In PIH patients 1 patient (0.5%) gave the history of previous IUD 
at 34 weeks after a bout of high fever for 3 days. There was history of 
previous abortions of about 10 (5%).
Table - 7
Past and family history of hypertension (Mother, Father 
I degree relative)
Group
History of Hypertension in 
the previous pregnancy
History of 
Hypertension in the 
family
No. of 
Patients
%
No. of 
Patients
%
Normotensive Nil - 14 7
PIH 29 14.5 19 9.5
In normotensive control no one gave the history of hypertension 
in  the  previous  pregnancy)  but  14  cases  (7%)  gave  history  of 
hypertensive disorder in the family members (father, mother, sibling).
In  PIH  patients  29  cases  (14.5%)  gave  the  history  of 
hypertension  in  the  previous  pregnancy  (recurrent  PIH),  19  cases 
(9.5%) gave the history of hypertension in the family.
Table - 8
Complication during present pregnancy
Nature of Complication Normotensive(Control pts 200)
Mild PIH 92 
patients
Severe PIH 68 
patients Eclampsia
Total 
percentage in 
PIH patients
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Anemia 45 22.5 14 7 9 4.5 25 12.5 24
Hypoproteinemia 7 3.5 6 3 9 4.5 24 12 19.5
APH Nil - - - 3 1.5 1 0.5 2
PPH 1 0.5 - - 1 0.5 1 0.5 1
Mal presentation 7 3.5 5 2.5 2 1 2 1 4.5
Mal Position 5 2.5 3 1.5 2 1 3 1.5 4
UTI Nil - 6 3 18 9 23 11.5 23.5
Diabetes Mellitus Nil - 4 2 2 1 1 0.5 3.5
Multiple Pregnancy 1 0.5 Nil - Nil - Nil Nil Nil
Abnormal Liver Function test Nil - Nil - 43 21.5 37 18.5 40
HELLP (DIC) Nil - Nil - Nil - 3 1.5 1.5
Fever Nil - 5 2.5 7 3.5 19 9.5 15.5
Aspiration Nil - Nil - Nil - 16 8 8
Renal Failure Nil - Nil - Nil - 3 1.5 1.5
External Injury Nil - Nil - Nil - 15 7.5 7.5
PROM 19 9.5 7 3.5 11 5.5 9 4.5 13.5
PPROM Nil - Nil - Nil - 4 2 2
In normotensive control 45pts (22.5%) suffering   from anemia. 
7(3.5%)  were   hypoproteinemic.  No  ante  partum  haemorrhage, 
1(0.5%) post partum haemorrhage, 7 (3.5%) mal presentation (all are 
breech) 5 (2.5%) mal position,   no urinary tract infection, no Diabetes, 
1 (0.5%) twin pregnancy,  20 elevated liver function test,  no HELLP 
syndrome,  no  fever,  no  aspiration,  renal  failure  or  external  injury, 
where as 19 (4.5%) developed premature rupture of membranes but 
no PPROM (preterm PROM).
In mild PIH (92cases) – 14 (7%) were anemic,  6 cases (3%) were 
hypoproteinemic, no APH or PPH 5 cases (2.5%) of mal presentation, 
3 (1.5%) cases of malposition, 6 (3%) had UTI 4 (2%) had associated 
gestational diabetes, no multiple pregnancies, no abnormality in LFT 
no HELLP syndrome, no aspiration,  severe renal  failure or  external 
injury. 5 cases (2.5%) had fever, 7 cases (3.5%) developed PROM no 
PPROM.
In  severe  PIH  (68cases)  9  (4.5%)  were  anemic  9  (4.5%) 
hypoproteinemic 3(1.5%) developed APH, all 3 are abruption grade I, 
one  (0.5%)  case  of  severe  atonic  PPH.  2  (1%)  malpresentation. 
2(1%) malposition,  18 (9%) developed UTI mostly catheter induced, 
associated  GDM  2  (1%),  no  multiple  pregnancy,  43  (21.5%)  had 
abnormal  LFT  without  HELLP  syndrome,  none  developed  HELLP, 
fever  in 7 (3.5%) no aspiration,  severe renal  failure,  external  injury. 
PROM in 11 cases (5.5%), but no PPROM.
In  Eclampsia  (40cases)  25  (12.5%  )  were  anemic  24  (12%)  were 
hypoproteinemic,  1 (0.5%) developed APH (abruption grade II), PPH 
in 1 (0.5%) malpresentation in 2( 1%) cases, malposition in 3 (1.5%) 
cases,  23  (11.5%)  had  UTI,  GDM  -1case  (0.5%)  no  multiple 
pregnancy,  abnormal  liver  function  test   without  overt  HELLP 
syndrome  in 37 (18.5%) cases,  HELLP  syndrome in 3 (1.5%) cases, 
19 pts  (9.5%) developed fever , 16 (8%) had aspiration, 3 patients 
(1.5%) developed severe renal failure, 15 (7.5%) had external injury 
due to fits, PROM in 9 (4.5%) cases, PPROM  in  4 (2%) cases.
Table - 9
CLINICAL FEATURES
Oedema in normotensive and PIH patients
Grading of 
Oedema
Normotensive 
control 200 
cases
Mild PIH 
92 patients
Severe PIH 
68 patients
Eclampsia
40 pts
No. of 
Patient
s
% No. of Patients %
No. of 
Patients %
No. of 
Patients %
No 
Oedema
48 24 Nil - Nil - Nil -
Grade I 
edema up 
to ankle
143 71.5 61 30.5 11 5.5 Nil -
Grade II up 
to Shin
9 4.5 21 10.5 22 11 5 2.5
Grade III 
Abd wall 
edema
Nil - 10 5 28 14 6 3
Grade IV 
(Anasarca)
Nil - Nil - 7 3.5 29 14.5
In  normotensive  (control)  patients  48  cases  had  no  Oedema 
legs. Where as 143 (71.5%) cases had Oedema up to ankle (bilateral 
pitting pedal Oedema –Grade-I) 9 cases (4.5%) had grade II Oedema 
(Oedema up to shin). No one had grade III and IV Oedema.
In mild PIH of 92 patients, 61 (30.5%) had edema grade I, 21 
(10.5%) had edema gradeII, 10 (5%) cases had edema grade III. No 
one had edema grade IV.
In  severe  PIH (total  68)  11  (5.5%)  pts  –  grade  I  edema,  22 
(11%)  grade  II.  28  cases  (14%)  grade  III,  7  (3.5%)  pts  developed 
grade IV edema.
In eclamptic patients (40 cases) 5 (2.5%) had edema grade II, 6 
(3%) grade III and majority 29 cases (14.5%) had edema grade IV.
Table - 10
Albuminuria
Grading
Normotensive
200 patients
Mild PIH 
92 patients
Severe PIH 
68 patients
Eclampsia
40 pts
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Nil or 
faint 
trace
196 98 3 1.5 Nil - Nil -
1+ 4 2 64 32 21 10.5 1 0.5
2+ Nil - 25 12.5 28 14 10 5
3+ & 
above
Nil - Nil - 19 9.5 29 14.5
4 (2%)  patients  out  of  200  normotensive  (control)  group  had 
Albuminuria.
In  mild  PIH  (92cases)  –  64  patients  (32%)  had  1+,  and  25 
patients (12.5%) had 2+ Albuminuria.
In severe PIH ( 68cases), 21 pts (10.5%) had 1+  &  28 patients 
(14%) had 2+ & 19 patients (9.5%) had 3+ and above albuminuria.  In 
Eclampsia ( 40cases), 1 pt (0.5%) had 1+  &  10 patients  (5%) had 2+ 
& 29 patients (14.5%) had 3+ and above albuminuria In these 200 PIH 
patients 57 patients ( 28.5%) had 24 hrs urinary protein > 300mg/L . 
Urine Specific gravidity range 1012 to 1014.
HYPERTENSION
Total of 200 PIH patients 92 patients (46%) had diastolic BP > 
90 but <110 mm Hg and classified under mild PIH. Rest of the 108 
(54%)  patients  are  severe  PIH  patients  i.e.  their  diastolic  BP  is 
>110mmHg.Of these 40 (20%) patients developed eclamptic fits.
Table - 11
Fundus examination in PIH Patients
Fundus Changes No. of PIH Patients %
Normal Fundus 130 65
Grade I retinopathy 61 30.5
Grade II 9 4.5
Grade III Nil -
Grade IV Nil -
In  200 total  PIH patients 130 cases (65%) were found to be 
normal during Fundus examination. Prevalence of grade I retinopathy 
in 61 patients (30.5%) & grade II retinopathy in 9 cases (4.5%). No pts 
had grade III or IV changes.
Table - 12
Biochemical Changes
Bio chemical 
parameters
Mild PIH 
92 patients
Severe PIH 
68 patients
Eclampsia
40 pts
Control Group
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Blood  urea  > 
40mg / dl
Nil - 22 11 25 12.5 Nil -
Blood  UricAcid 
> 4.5 mg/dl
23 11.
5
54 27 33 16.5 Nil -
Sr.  Creatinine 
> 1mg%
Nil Nil 38 19 34 17 Nil -
Sr.Fibrinogen 
< 200 mg/ dl
9 4.5 46 23 31 15.5 Nil -
Hb  %  Mild  8.5 
gm to 11 gm%
48 24 29 14.5 18 9 45 22.5
moderate 6.5 to 
8.4 gm%
3 1.5 5 2.5 19 9.5 Nil -
Severe < 6.5gm
%
Nil - 1 0.5 3 1.5% Nil -
Serum  bilirubin 
total > 1.2mg%
Nil - 8 4 13 6.5 Nil -
Serum  total 
proteins < 6 gm
33 16.
5
23 11.5 19 9.5 7 3.5
LFT rise Nil - 17 8.5 18 9 Nil -
Platelet  count  < 
1 Lk/cmm
Nil - Nil 5 2.5 Nil -
40mg/dl is taken as cut off value for blood urea, no one were 
above this is mild PIH group. 22 cases (11%) of severe PIH and 25 
patients (12.5%) of Eclampsia group were above this level. 23(11.5%) 
of mild PIH cases, 54 (27%) cases of severe PIH and 33 (16.5%) of 
cases of Eclampsia were having rise in serum uric acid level above 
4.5% mg/dl.
38 (19%) of severe PIH and 34(17%) of Eclampsia patients, had 
rise in serum creatinine more than1mgs%
9 cases (4.5%) of mild PIH and 46 (23%) of severe PIH & 31 
(15.5%) of Eclampsia pts were having serum fibrinogen level less than 
200mg /dl. In mild PIH patient 48(24%) were mildly anemic, 3 patients 
(1.5%) were moderately anemic. In severe PIH 29 (14.5%) were mildly 
anemic  5  (2.5%)  were  moderately  anemic  1  patient  (0.5%)  was 
severely  anemic.  In  Eclampsia18  (9%)  were  mild,  19(9.5%)  were 
moderate and 3 (1.5%) patients were severely anemic.
In mild PIH nobody had serum bilirubin > 1.2mg%
In severe PIH 8 cases (4%) had total bilirubin more than 1.2 mg
% where as it was 13 (6.5%) in eclamptic patients.
In  mild  PIH  33  cases  (16.5%)  had  less  than  6  Gms  total 
proteins, where as it were 23 (11.5%) patients in severe PIH and 19 
(9.5%) cases in eclamptic group.
Rise in liver function test is not seen in mild PIH group, but it 
was present in 17 case (8.5%) in severe PIH group and 18 (9%) cases 
in eclamptic group.
Platelet count less than 1 lakh / cmm (thrombocytopenia) was 
seen only in eclamptic group of about    5 cases (2.5%)
In control  group,  all  other  parameters were  normal except  45 
cases (22.5%) of mild anemia & 7 (3.5%) of Hypoproteinemia..
In both control group and PIH group the electrolyte (Na+, K+  Cl- 
HCO) were normal.
Table - 13
Mode of Delivery
Mode of 
Delivery
Mild PIH 
92 patients
Severe PIH 
68 patients
Eclampsia
40 pts
Normotensive 
Control
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Labour 
Natural
58 29 38 1
9
14 7 104 52
LMC 
Forceps
6 3 5 2.
5
Nil - 17 8.5
Outlet 
Forceps
7 3.5 6 3.
5
8 4 32 16
Vacuum Nil - Nil - Nil - 4 2
LSCS 21 10.5 19 9.
5
18 9 43 21.5
In 200 normotensive control 104 (52%) delivered labour natural, 
17 (8.5%) by Low midcavity Forceps delivery,  32(16%) delivered by 
outlet forceps and 4 (2%) cases delivered by vacuum. Lower segment 
caesarean section in 43(21.5%) cases
In mild PIH group 58(29%) Labour natural, 6(3%) LMC forceps 
delivery, 7 cases (3.5%) delivered by outlet forceps, No vacuum, 21 
pts  (10.5%)  had LSCS.  In  severe  PIH group 38(19%)  delivered  by 
labour natural 5(2.5%) delivery LMC forceps, 6 cases (3.5%) delivery 
by outlet, no vacuum, 19 cases (9.5%) delivered by LSCS.
In  Eclampsia  labour  natural  is  14  (7%),  No  LMC  forceps 
delivery,  no vacuum delivery, 8 cases (4%) deliver by outlet forceps 
and LSCS for 18(9%) cases.
TABLE – 14
Gestational age at delivery
Gestational age at 
the time of delivery
Control group PIH group
No. % No. %
> 37 weeks 182 91 117 58.5
34 to 37 weeks 18 9 44 22
28-34 weeks - - 21 10.5
<28 weeks - - 18 9
In  normotensive  control  majority  182  cases  (91%)  delivered 
above 37 completed weeks. Few cases – 18 (9%) delivered before 37 
weeks but after 34 weeks.
In PIH Patients  117 cases  (58.5%) delivered at the gestational 
age above 37  completed weeks. 44 cases (22%) delivered  between 
34-37 weeks. 21 cases (10.5%) delivered between 28 to 34 weeks, 
and 18 cases  (9%) delivered before 28 weeks.
Table - 15
Indications for LSCS
Indications in PIH patient In control
No. of 
Patients %
No. of 
Patients %
Fetal distress 26 14 12 6
Failed 
induction
20 10 11 5.5
Mal 
presentation 
(primi breech)
3 1.5 7 3.5
Previous LSCS 
with CPD
5 2.5 13 6.5
Uncontrolled 
APE
2 1 nil -
Of the total  no  of  58  LSCS patients  in  PIH group,  28 cases 
(14%) were indicated for fetal distress, 20 (10%) for failed induction, 3 
case (1.5%) were primi with breech presentation. Previous LSCS with 
CPD as an indication for repeat LSCS in 5 cases (2.5%), uncontrolled 
Ante partum Eclampsia in 2 cases 1%.
In control group of the total 43 LSCS patients fetal distress as a 
indication  for  12  cases  (6%)  Failed  induction  in  11  cases  (5.5%) 
malpresentation  in  7  (3.5%)  cases;  previous  LSCS  with  CPD  in 
13(6.5%) cases.
Table - 16
Type of Induction / Acceleration of Labour
Type of 
Induction / 
Acceleration
Normotensive 
200
Mild PIH 
92 patients
Severe PIH 
68 patients
Eclampsia
40 pts
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
No. of 
Patients %
Spontaneous
onset
88 44 26 13
.5
16 8 7 3.5
ARM / Synto 
for 
acceleration
58 29 12 6 13 6.
5
7 3.5
PG induction 37 18.
5
49 24
.5
39 19
.5
23 11.5
ElectiveLSCS 17 9.5 5 2.
5
Nil - 3 1.5
P =0.000  X2 =55.43 Statistically SIGNIFICANT
In control group spontaneous onset of labour in 88 (44%) cases, 
artificial rupture of membrane / oxytocin for augmentation of labour in 
58  cases  (29%),  PG  induction  in  37  (18.5%)  cases.  Elective 
LSCS-17cases (8.5%).
In mild PIH group spontaneous onset of labour in 26 (13.5%) 
cases, ARM/ oxytocin augmentation in 12 (6%) cases, PG induction in 
49 cases (24.5%)   Elective LSCS –5 pts (2.5%)
In severe PIH group spontaneous onset of labour in 16 cases 
(8%), ARM / Oxytocin augmentation in 13 cases (6.5%), PG induction 
in 39 (19.5%) cases. No Elective LSCS.
In Eclampsia group spontaneous onset of labour only in 7 cases 
(3.5%),  ARM  /oxytocin  augmentation  in  7  (3.5%),  cases,  PGE2 
gel/PGF2α tablet  induction  in  23  cases  (11.5%).  Elective 
LSCS-3cases (1.5%)
Table - 17
One minute Apgar of the baby in Normotensive patients and PIH
Apgar
PIH Control
No. of 
Patients %
No. of 
Patients %
1/10 to 4/10 16 8 8 4
5/10 to 6/10 18 9 17 8.5
> 7/10 133 66.5 168 84
Dead born / 
still born
33 16.5 7 3.5
Early 
Neonatal 
death
16 8 14 7
P =0.00002934  X2 =23.67 Statistically SIGNIFICANT
In control group, the one minute Apgar was> 7/10 in 168 cases 
(84%). In 17 cases (8.5%) it is 5/10 to 6/10. In 8 cases (4%) it is 4/10 
to 1/10.
In PIH patients 133 cases (66.5%) had one minute Apgar more 
than 7/10. In 18 cases (9%) it is 5/10 to 7/10. In 16 cases (8%) one 
minute Apgar was between 1/10 to 4/10.
Total  number  of  dead  born  (or)  Stillborn  in  control  group  is 
7(3.5%).
In PIH group it is 33 (16.5%). Early neonatal  death in control 
group was 14(7%). In PIH group it was 16 (8%).
Table - 18
Sex Incidence of babies
Group
Male babies Female babies
No.  of 
Patients
%
No.  of 
Patients
%
Control 108 54 92 46
PIH 103 51.5 97 48.5
P =0.61  X2 =0.25 Statistically NOT  SIGNIFICANT
In  control  group  108 (54%)  delivered  male babies.  92  (46%) 
delivered  female babies.  In  PIH group  103 (51.5%)  delivered  male 
babies, 97(48.5%) delivered female babies.
Table - 19
Weight of the baby
Weight
Control Group PIH
No. of 
Patients
%
No. of 
Patients
%
> 3.5 kg 11 5.5 9 4.5
3 to 3.4 kg 66 33 45 22.5
2.5 to 2.9 kg 102 51 64 32
2 to 2.4 kg 21 10.5 39 19.5
<2kg nil - 43 21.5
P =0.000  X2 =49  Statistically SIGNIFICANT
In Control group 102 babies (51%) were between 2.5 to 2.9 kg, 
66 (33%) were between 3 to 3.4 kg, 21 babies (10.5%) were between 
2 to 2.4 Kg, 11 babies (5.5%) were equal (or) above 3.5 Kg, no baby 
was less than 2 Kg.
In PIH group 64 babies (32%) were between 2.5 to 2.9 kg, 45 
babies (22.5%) were between 3 to 3.4 Kg, 39 babies (19.5%) were 
between 2 to 2.4 Kg, 9 babies (4.5%) were equal (or) above 3.5 kg, 43 
babies (21.5%) were less than 2Kg.
Number of preterm babies in PIH group (<2 kg) were 43 (21.5%) 
none in control group.
Table - 20
Kick count valuation (Average) 12 hrs
Period of 
gestation in 
weeks
Primi Multi
PIH Normotensive PIH Normotensive
21 to 30 
weeks
64 66 77 82
31 to 36 
weeks
70 70 78 82
37 week  & 
above
36 63 75 80
Table shows that DFMC in both primi & multi  Para had been 
similar in both normotensive & PIH patients.
Table – 21
Average BPD
Period of gestation BPD MeasurementNormotensive PIH
22 weeks 5.9 cm 5.8 cm
24 weeks 6.2 cm 6 cm
26 weeks 6.8 cm 6.6 cm
28 weeks 7.4 cm 7.3 cm
32 weeks 8.2 cm 8.1 cm
36 weeks 8.9 cm 8.6 cm
38 + 3 weeks 9.3 cm 9.2 cm
The average B.P.D. values in both normotensive and PIH were 
almost nearer. BPD values in Hypertensive cases were little less; but 
negligible.
Table -22
Growth Rate Of BPD In Control & PIH Patients
Duration of 
pregnancy in 
weeks
Normal Mild PIH
SeverePIH & 
Eclampsia
21 to 32 weeks 2.8 mm/wk 2.7 mm/wk 2.5 mm/wk
33 to 40 weeks 1.8 mm/wk 11.7 mm/wk 1.5 mm/wk
The BPD growth rate in mild PIH is similar with normotensive 
cases. But there is a definite decrease in growth of BPD in severe PIH 
and Eclampsia patient.
Table -23
FEMUR LENGTH IN NORMOTENSIVE/ HYPERTENSIVE PATIENTS
Duration  in 
weeks
FL in cm
Normotensive Mild PIH
Severe 
PIH/Eclampsia
22 weeks 3.9 cm 3.9 3.8 cm
24 weeks 4.2 cm 4.2 4.2 cm
26 weeks 4.9 cm 4.8 4.8 cm
29 weeks 5.6 cm 5.5 5.5 cm
32 weeks 6.3 cm 6.2 6.1 cm
35 weeks 6.9 cm 6.8 cm 6.7 cm
38 + 3 cm 7.5 cm 7.4 cm 7.2 cm
The  femur  length  in  different  weeks  of  pregnancy  in  both 
normotensive & Hypertensive (Mild PIH, Severe PIH and Eclampsia) 
were similar.
Drugs used in Hypertensive disorders in pregnancy.
1. Sedatives- Pethidine, Diazepam, promethazine
2. Antihypertensive  –  Tab.Alphamethyldopa,  Tab.Nifedipine, 
Sublingual Nifedipine.
3. Anti convulsant-Magnesium sulphate, phenytoin.
DISCUSSION
According  to  ACOG  incidence  of  preeclampsia  -5  to 
8%.Incidence of preeclampsia in KMC is 11%.Considering the age 
groups,  the  maximum number  of  patients  were  found  between  the 
ages of the 21-25 years, 44.5% and 42% in normotensive group& in 
PIH complicating pregnancy respectively. This shows that in this study 
the  child  bearing  period  is  earlier  when  compared  to  advanced 
countries  where  number  of  elderly  primigravidae  are  encountered. 
Young  pts  <20&>30yrs  said  to  have  increased  incidence  of 
preeclampsia(AMJ  of  O&G  1993).In  10  years,  1958-1967,  in 
Aberdeen  city,  the  incidence  of  severe  pre-Eclampsia  in  first 
pregnancy was 4.8% varying from 4.2% in 15-19 years age group 
to 6.5% in those of 30 years of age and more. 
Studying the gravidity and parity in the normotensive group &, 
pre-Eclampsia  in  200  cases,  it  is  found  that  mild,  severe  pre-
Eclampsia  and Eclampsia  occurred  in primi  Gravida  more than the 
others.(Mild-29% Severe-18% Eclampsia-13%,Total=60%) as studies 
in  literature. Majority  of  cases  say  75  to  80%  occur  during  1st 
pregnancy.(Clinical  Obstetrics&  Gynecology  journal  
volume 42). In Aberdeen city study by Nelson (1955) showed that 
75% of all cases of pre-Eclampsia occurred in 1st pregnancy. 
In our series of 200 cases, there were 29 cases (14.5%) with 
recurrent pre-Eclampsia. Sibai et al (37) showed risk of developing 
pre-Eclampsia  in  next  pregnancy  being  45.5%.  Out  of  them 
21%go for severe pre-Eclampsia. On analyzing the number of cases 
who  were  registered  and  unregistered,  among  the  92  Mild 
preeclampsia 22 cases (11%) were booked while rest unbooked. In 68 
severe pre-Eclampsia patients 52pts (26%) were unbooked and rest 
were booked. Among the 40 cases of Eclampsia 34cases (17%) were 
unbooked. In control group 78cases (39%) were unbooked. The high 
percentage  of  unbooked  cases  in  preeclampsia  indicates  that 
these patients attended the hospital only when they have some 
complaints like edema feet, scanty micturition or giddiness and 
found to have increase of blood pressure. 
On  analysis  the  incidence  of  pre-Eclampsia,  Eclampsia   in 
relation  to  social  class  Table-5  shows  that  majority  of  our  patients 
belong  to  the  lower  socio-economic  strata,  where  there  is  poor 
nutrition  and  associated  with  conditions  like  anemia  and 
Hypoproteinemia.
Considering the clinical aspects of hypertensive disorders,  the 
three  important  clinical  features  –  hypertension,  edema  and 
Proteinuria are changes of which the pregnant women are unaware 
except edema. By the time she has developed symptoms and signs 
that  she  herself  can  detect  such  as  headache,  visual  disturbance, 
puffiness of the face and fingers, the disorder is usually advanced. 
Among  the  various  clinical  features  noted  in  200  cases  of 
hypertensive  disorders  complicating  pregnancy  the  obvious  gross 
finding was edema. There is a problem in determining what constitutes 
a  normal  pregnancy  particularly  with  regard  to  clinical  edema. 
Normality  can  be  accepted  in  terms  of  absence  of  any  obvious 
complications or any changes which has been shown to be associated 
with  maternal  morbidity  or  mortality.  But  this  criteria  hypertension 
along with Proteinuria  can be seen to  be  abnormal  since  it  is 
associated with increased fetal loss (Nelson 1955). Clinical edema 
alone on the other hand has not been clearly shown to be associated 
with increased morbidity or mortality and must, therefore probably be 
considered as physiological.
Our study shows that edema increases with hypertension 
and  when  it  is  associated  with  anemia,  hypoproteinemia,  it  took  a 
longer time to clear up. There was more number of anemic patients 
in preeclampsia. The most cardinal  sign is hypertension. Blood 
pressure  was  checked every  hour  during  labour  and 4 hourly  after 
delivery.  Blood  pressure  was  recorded  48hrs,  72hrs,  1wk, 
4wks&6wksafterdelivery.
ALBUMINURIA IN HYPERTENSIVE DISORDERS COMPLICATING 
PREGNANCY
Proteinuria varies greatly not  only from individual  to individual 
but also in the same women from time to time. The variability points to 
a  functional  (Vaso-spasm)  rather  than  an  organic  cause.  In  early 
preeclampsia, Proteinuria may be minimal or entirely lacking. In more 
severe  grades,  proteinuria  is  usually  demonstrable  and  may be  as 
much  10gm/L.  Proteinuria  almost  always  develop  later  than  the 
hypertension and usually later than excessive weight gain. 
In our study mild PIH cases showed either traces or mild 
albuminuria.  The moderate and heavy proteinuria was found in 
severe  PIH  and  Eclampsia  cases  thereby  showing  that  the 
incidence of proteinuria increases with severity of PIH. 
MATERNAL COMPLICATIONS vise
Study APH HELLP/DIC RENAL FAILURE
Hall&colleagues2000 20% 5% 0.3%
Vissur&Wallenburg1995 5% -- --
MurphyDJ & StirratGM 
2000(22)
1.5% 21% 1.3%
OlahKS,Redman CW,Ge 
eH1993
-- 14.2% 1.1%
Our study 2% 1.5% 1.5%
Our  study  showed  relatively  low incidence  of  APH & HELLP 
than Halls study. Renal failure correlating with Murphy’s study. 
The most common complication during pregnancy in 200 cases 
of hypertensive disorder complicating pregnancy was anemia.  
MANAGEMENT
When Eclampsia develops ante partum or Intra partum the 
outlook   for  Mother  and  baby  is  worse  when  the  delivery   is 
delayed as Menon 1961 and HopesLera 1967 have shown in this 
series
Time  for 
convulsion  up 
to delivery
Maternal 
Mortalit
y
0-2 hrs 7
2-4 hrs 13
4-8hrs 19
8-12hrs 25
12-24hrs 32
24hrs 42
Delivery  should  therefore  be  promptly  effected  by  whatever 
means as this  carries  best  prognosis  for  mother and baby.  Menon 
(1961) showed caesarean section to be safe when performed at 
the right  time,  when  he reported loss of  only one case of  42 
eclamptic  delivered  by  caesarean  section  during   a  5  years 
period. 
Crichton,  Notelovitz  and  Heller  (19678)  demonstrated 
improvement in perinatal mortality by early caesarian section of 
antepartum  eclamptics. In  240  cases,  delivered  abdominally, 
perinatal mortality was 35% compared with 47% in 83 cases  delivered 
vaginally, the maternal mortality being equal. The improved prospects 
for babies weighing between 1360-2768gm. Lopex Llera (1967) also 
reported improved fetal results from caesarian section.
However it would seem reasonable to attempt vaginal delivery 
by  inducing  labour  and  monitoring  the  foetus  carefully.  Whatever 
method  of  delivery  is  chosen,  avoidance  of  haemorrhage  and 
operative shock are important. 
Due to their pre existing hypovolemia and haemoconcentration, 
any blood loss is badly tolerated. Blood loss greater that 250 ml should 
be replaced by transfusion immediately irrespective of  pre-operative 
hemoglobin level. 
DRUGS 
Drugs  used  in  the  treatment  of  hypertensive  disorders 
complicating  pregnancy  in  mild  and severe  variety  of  preeclampsia 
were mainly sedatives and anti hypertensive. 
The sedatives  used were  Pethidine  hydrochloride,  Diazepam, 
promethazine, chlorpromazine , phenytoin, magnesium sulphate.   
Mannitol  was  given  in  doses  of  175ml  intravenously  in 
Eclampsia  to  reduce  the  cerebral  edema.  Anti  hyper  tensive  used 
wereT.Nifedipine,  T.Alpha  methyl  dopa,  Magnesium  sulphate 
(50%).PRITCHARD regime followed.
The new born were examined soon after birth and Apgar at 1 mt 
noted. In Eclampsia&severe PIH, as described in literature the babies 
are  in  an  unfavorable  uterine  environment  in  the  later  weeks  of 
pregnancy and the  intrauterine hypoxia  is  greater  when  compared 
with   normotensive  pregnancy  and  the  distress  increases  as  the 
severity of the disease increases. 
WEIGHT OF THE NEW BORN
In our study The birth weight was more in the mild variety than 
the severe PIH, hence the fetal prognosis in mild variety is better. 
SEX INCIDENCE OF NEW BORN 
In  our  series  of  200  cases,  of  hypertensive  disorders 
complicating  pregnancy,  51.5% of  the new born  were  male,  48.5% 
were female.  The incidence of PIH seems to be associated with 
carrying  a  male  foetus,  as  reported  byButtner  (1903), 
Hammershalf  (1904),  Kushner  (1931),  Salzmann (1955),  Chesley 
(1978)  and  a  study  conducted  in  Aberdeen  City  between 
1967-1979 and Doris M. Campbell andlan Mc Gillivary 1983.
Author No. of 
Pregnancies
Male Female Sex Ratio
Buttner 1903 1782 966 816 1.18
Hammershalf 1904
Kushner 1931
Salzmann 1955
Chesley 1978
297
2013
421
274
161
1155
222
128
136
850
199
146
1.18
1.35
1.12
0.88
Sex ratio at birth is No. of males born for every 100 female.
Dr. Shirin Mehtaji has stated in her series of study in Camas 
and  Albles  Hospital,  Bombay,  that  the  incidence  of  perinatal 
mortality due to hypertensive disorders complicating pregnancy 
being 15.63/ 1000 total births.  In our study  the perinatal mortality 
rate due to PIH is 26.2/ 1000 total births.
Among the normotensive patient monitored the outcome for both 
the mother and foetus is satisfactory. In normotensive patient rate of 
growth of BPD was 2.8 mm/wk up to 32 wks, and 1.8 mm/wk from 33 
wks  onwards.  The fetal  birth  weight  within  normal  curve.  All  cases 
showed  positive  non-  stress  test.  The  fetal  birth  weight  in  these 
patients is majority in the range of 2.5to3kg. 
Of  the  156  cases  of  unbooked  hypertensive  pregnancies  70 
were  mild  Preeclampsia  52,  were  severe  Preeclampsia,  34  were 
Eclampsia.  Regarding  maternal  fetal  complications unbooked cases 
were having more complications than booked one. 
Complications Total Cases Unbooked PIH Booked PIH
Anemia 48 41
Hypoproteinemi
a 
39 32 7
APH 4 3 7
PPH 2 2 -
Malpresentation 9 8 1
Malposition 8 6 2
UTI 47 43 4
DM 7 6 1
Abnormal LFT 80 63 17
HELLP 3 3 -
 Fever 31 27 4
Aspiration 16 13 3
Renal failure 3 3 --
Ext. Injury 15 12 3
PROM 27 23 4
PPROM 4 3 1
Of the total 48 cases of  anemia 41 were unbooked. 3 APH out 
of 4, all 2 PPH, 8 out of 9 malpresentation and 6 out of 8  malposition 
were  unbooked  cases. 43 out of 47 cases  of UTI, 6 DM, 63 abnormal 
LFT, 27 fever cases, 13 aspiration cases, 12 external injury were seen 
in unbooked patients.  All  3 cases who developed HELLP syndrome 
died were unbooked. Of the 27 PROM and 4 PPROM cases 23 PROM 
and 3 PPROM were unbooked. 
Regarding fetal complications of the total 33 dead born/still born 
babies 27 were unbooked and in 16 cases of neonatal death 10 were 
unbooked. 
This study clearly indicates the  importance of booking in terms 
of maternal, fetal morbidity and mortality. 
The  few  frequent  complications  were  Eclampsia,  IUGR,  and 
ante partum haemorrhage and intra uterine death.  In the monitoring 
and  regular  follow up  in  the  200cases  of  PIH many  aspects  were 
analyzed. 
This disorder was seen more frequently in primigravida than in 
multigravidea.   Even  in  primigravidae  very  young  primi  (age  group 
16-19  years)  and  elderly  primi  (age  group  30-34  years)  were  very 
commonly affected.  In this group taken for analyses,  92pts were of 
milder variety and 68pts were of severe variety. This shows that the 
disease usually takes a milder form at the onset in majority of cases, 
when  hypertension  and  proteinuria  were  definite  criteria  of  the 
disorder.  Cases especially  mild  hypertensive  types  were  presenting 
without edema. But at the same time edema had been one of the triad 
of symptoms in severe PIH cases. 
All patient of PIH were admitted in the hospital for investigations. 
Mild cases responded well with bed rest, sedatives, anti hypertensive 
(if needed) improved nutrition, and were then treated as outpatient with 
a weekly  antenatal  checkup.  Severe cases needed admission for a 
longer duration. 
The  kick  count  maintained  by  both  primigravidae  and 
multigravidea. The  USG      examinations  of  the  various  fetal 
parameters  done  at  3-4  weeks  interval  showed  an  almost  normal 
growth rate of biparietal diameter, femur length in mild  preeclampsia. 
The  growth  rate  though  very  slightly  lesser  in  milder  hypertensive 
women,  it  was negligible.  But at  the same time, the growth  rate of 
different parameters in  severely hypertensive  women were notably 
lesser  than the normal pregnancies. The BPD growth rate in mildly 
hypertensive women was 2.8 mm/wk from 24-32 wks and 1.88 mm/wk 
from  32  wks  onwards.  The  similar  measurement  in  severely 
hypertensive women was 2.5 mm/wk from 24-32 wks and 1.5 mm/wk 
from 32 wks onwards. 
REGARDING INDUCTION WITH PROSTAGLANDIN 
Indications for PG induction 
PG Induction in Eclampsia – 23 cases 
PG induction in severe PIH - 39 cases
PG induction  in  mild PIH - 49 cases 
Those  who  had  Eclampsia  induction  was  done  for  maternal 
goodness in 19 cases.  4 cases induced for PPROM before  34 weeks. 
Of  the  39  cases  of  severe  Preeclampsia  induced  with  PG
20 cases  were induced for fluctuating  BP, not properly controlled with 
anti-hypertensive  drugs.  9  cases  were  induced  for  37  completed 
weeks (term). Remaining 10 cases were induced  for PROM.
Of the 49 cases of mild Preeclampsia induced with PG-7 cases 
for PROM, 42 for term. 
REGARDING THREE MATERNAL DEATHS 
All three maternal deaths were unbooked cases
- Two Primi –  one 18 yrs  old & one 36 yrs old and one G2 
P1 L1 24 yrs old.
- All three  are antepartum eclampsia, developed  HELLP 
syndrome  and succumb  to death  in spite of   termination 
of pregnancy  and aggressive  supportive  treatment for 
the condition. 
SUMMARY
Incidence of preeclampsia  in KMC is  11%.  In our study there 
were 200 patients of mild, severe preeclampsia and Eclampsia were 
compared   with 200 normotensive patients in terms of maternal  and 
perinatal out come. 
- 60% of the preeclampsia Eclampsia patients were primi. 
- 42% were in the age group 21-25 years. 
- 78% were un booked
- 98%of them belong to class 4or 5 socio economic status. 
-  5.5% had history of previous abortions and / or IUD.
- 14.5%were recurrent PIH
- About 9.5% had history of Hypertension in the family. 
- Complications  like  anemia,  hypoproteinemia,  antepartum 
Haemorrhage,  post  partum  Haemorrhage,  urinary  infection 
and  abnormal  liver  function  test,  fever,  aspiration,  severe 
renal failure, HELLP   syndrome, and external injury due to 
fits  are  more  in  patients  with  PIH mainly  severe  PIH and 
Eclampsia. 
- 3 Patients developed HELLP syndrome, and all 3 died. 
- Clinical  features  like  grading  of  Oedema  and  albuminuria 
were in ascending order with severity of PIH. 
- 65% of PIH patients were having normal Fundus examination 
but  30.5%  had  grade  I  retinopathy  and  4.5% had  grade  II 
retinopathy. 
- Regarding  biochemical  parameters-  With  severity  of  PIH 
there were ascending order of biochemical abnormality.
- 71% of them delivered via naturalis 
- LSCS was most commonly indicated for fetal distress (14%) 
- 55.5% of  PIH  patients  particularly  severe  variety  and 
Eclampsia were induced with prostaglandin.  
- 58.5% delivered at  term 
- 4% taken for elective LSCS.
- 66.5%of babies born to PIH mother were normal with good 
Apgar  ( >7/10 ) 
- 33 babies were dead born/still born. 
- 16 babies died in the early neonatal period. 
- There  was  a  slight  male  preponderance  among  babies 
(51.5%)
- 32%of the babies weighed between 2.5 to 2.9 kg.
- Total number of maternal death among PIH group is  3.  All 
three died due to HELLP syndrome
- Maternal mortality due to pregnancy induced hypertension is 
3 (1.5%) in 200 cases of PIH.
- Perinatal mortality rate = No of still born + neonatal death / 
1000 live birth. 
- In  our  study  the  perinatal  mortality  rate  due  to  PIH  is 
26.2/1000.
CONCLUSION
This   is  the   random study of   200  cases  of   maternal  and 
perinatal  outcome in mild and severe pre Eclampsia  and Eclampsia 
in comparison to the outcome in  200 normal gravidae.
Even though   it is a random study it shows that the occurrence 
of  preeclampsia   and  Eclampsia   are  found mostly in  unbooked 
cases. 
There  is   an increase  in  incidence of  maternal  and  perinatal 
morbidity  and  mortality  in  PIH  patients,  particularly  with  severe 
preeclampsia  and  Eclampsia.   This  study  clearly  illustrate  that  the 
regular  monitoring  of  antenatal  mothers  with  hypertension  during 
pregnancy and labour has a welcoming result  in modern obstetrics. 
Careful antenatal monitoring helps to identify the early warning signs 
of  Eclampsia.  Prompt  care  at  this  stage  is  often  successful  in 
preventing the high morbidity and mortality.   The need for monitoring 
the  pregnancy  for  early  detection  and  proper  management  of  a 
complication   of  pregnancy,  with  timely  intervention  as  regards 
termination of pregnancy  with facility for monitoring during labour and 
after care of the high risk infant, seems to play more important role in 
the final outcome. 
Both  the  foetus  and  maternal  factors  are  to  be  taken  into 
consideration. Once the blood pressure in these cases settles down 
with bed rest,  sedatives  and antihypertensive drugs, fetal  factors are 
to be considered and decision taken accordingly  to whether or not the 
foetus  is in difficulty or whether it might  benefit from continued intra-
uterine  maintenance.  If  tests  for  fetal  well  being  are  normal  and 
provided the mother’s condition does not threaten life, the pregnancy 
is allowed to continue until  fetal maturity is reached.
Once the fetal maturity is reached and confirmed by the various 
tests, termination of pregnancy is to be considered. Mode of delivery 
should be decided accordingly. This regimen of monitoring of PIH will 
definitely improve the pregnancy outcome. 
and 
More  awareness  to be created   regarding   early  and regular 
antenatal   check  up   to  improve  the   pregnancy  outcome  in  PIH 
patients. 
ABBREVATION 
1. ACOG - American Journal of Obstetrics and Gynaecology
2. AST - Aspartate Transaminase 
3. ALT - Alanine Transaminase 
4. AFI - Amniotic Fluid Index
5. A - Alive
6. AP  - Antepartum 
7. BJOG - British Journal of Obstetrics and Gynaecology 
8. BT - Bleeding Time
9. BP - Blood Pressure 
10. BMI - Body Mass Index 
11. CT - Clotting time 
12. DIC - Disseminated Intravascular Coagulation 
13. DM - Diabetes Mellitus 
14. EL - Eclampsia 
15. FD - Fetal Distress
16. GA - Gestational Age
17. HCG - Human Chorionic Gonadotrophin 
18. H2O2 - Hydrogen Peroxide 
19. IE - Imminent Eclampsia 
20. IP - Intrapartum 
21. ML - Mild Pre Eclampsia
22. ND - Neonatal Death
23. P - Primi 
24. PN loss - Perinatal Loss
25. PP - Postpartum 
26. PT - Prothrombin Time 
27. PE - Preeclampsia 
28. PIH - Pregnancy Induced Hypertension
29. PGI2 - Prostacyclin 
30.  NST - Non Stress Test
31. NICU - Neonatal Intensive care unit 
32. SVR - Severe pre Eclampsia 
33. T - Total
34. TG - Triglyceride 
35. TXA2 - Thromboxane A2
36. USG - Ultra sonogram 
37. VEGF - Vasoactive endothelial growth factor 
PROFORMA
1. SL. No.                                            :
2. Name  :
3. Age :
4. IP No :
5. Obstetric  score :
6. Gestational age at admission :
7. Socio economic status                    :
8. Height                                              :
9. Weight                                              :
10. Booked / un booked                       : 
11. H/O previous bad obstetric history 
Recurrent IUD/ Abortion :
12.  Any imminent symptoms :
13. Investigation 
a. Hb% :
b. Urine alb :
Sugar :
Deposit :
Bile salts, bile pigments :
c. Blood  urea, sugar :
d. Sr. creatinine :
 Na+│K+
e. Sr. electrolytes   -------------- :
         cl -│H co3 -
f. Sr. Uric acid :
g. Sr. fibrinogen :
h. Complete haemogram including
platelet count & peripheral
smear. :
i. LiverFunctionTests
ALT :
AST :
Alkalinephosphatase :
BT :
CT :
j. Sr. Bilirubin- Total, Conjugate :
k. Albuminuria Nil/ 1+/ 2+/3+/ >3+:
l. 24 hrs urinary protein :
14. Present history :
15. Relevant past  history- Medical  history
surgical  history :
16. Relevant  personal History :
17. Menstrual history :
18. Marital History :
19. Obstetric history :
20. Complication (maternal) during
present pregnancy like anemia
Hypoproteinemia etc. :
I –Trimester :
II – Trimester :
III- Trimester :
21. Drug History – present, past :
22. Gravidogram – Date, urine albumin,
wt, SFH, AC, BP, imminent
symptoms. :
23. Magnesium sulphate chart :
Time, dose, PR, RR, BP, Temperature,
Urine output, knee-jerk.  :
General examination :
PR :
BP :
Temperature :
CVS :
RS :
Anemia / Not :
Grading of edema- 0,1,2,3,4 :
P/A :
P/V :
25.  Mode of Delivery    Labour
natural / LSCS :
26. Mode of Induction/ acceleration :
27. Admission delivery interval :
28. If  LSCS – Indication for LSCS :
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